SEC Form 4 · accession 0001209191-17-019058

MAGELLAN HEALTH INC · MGLN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Officer — General Counsel and Secretary

Period of report

Mar 5, 2017

Accepted (ET)

Mar 7, 2017 · 7:36 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000019411

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Ordinary Common Stock, $0.01 par value^F2	Mar 5, 2017	M	1,156	$0.00	A	12,607	D
Ordinary Common Stock, $0.01 par value^F4	Mar 5, 2017	F	351	$67.30	D	12,256	D
Ordinary Common Stock, $0.01 par value^F2	Mar 5, 2017	M	2,093	$0.00	A	14,349	D
Ordinary Common Stock, $0.01 par value^F4	Mar 5, 2017	F	565	$67.30	D	13,784	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F2	$0.00	Mar 5, 2017	M	1,156	D	Mar 5, 2017	—	Common Stock	1,156	0	D
Restricted Stock Units^F2	$0.00	Mar 5, 2017	M	2,093	D	Mar 5, 2017	—	Common Stock	2,093	0	D

F1This transaction represents the vesting of 1,156 shares postponed from 2016. Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
F2Not applicable.
F3Represents the portion of shares withheld by the Company in order to pay taxes.
F4Closing price on NASDAQ on March 6, 2017.
F5This transaction represents the vesting of shares postponed from 2016 and the shares scheduled to vest in 2017 . Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.